Clinical Trials · NCT06901648
A Study of HS-20094 in Patients With T2DM
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Enrollment
- 275
- Start date
- Feb 2024
- Locations
- 1 site, China
- Primary endpoint
- The change of HbA1c in the patients